FDA takes steps to add molecular tests using pooled nasal specimens in serial testing program

Today, the U.S. Food and Drug Administration took steps to further facilitate the authorization of molecular tests for screening asymptomatic individuals using pooled anterior nasal respiratory specimens in serial testing programs.